Avanos Medical (AVNS) Research & Development (2016 - 2026)
Avanos Medical's Research & Development history spans 13 years, with the latest figure at $6.1 million for Q4 2025.
- On a quarterly basis, Research & Development rose 7.02% to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.3 million, a 11.07% decrease, with the full-year FY2025 number at $23.3 million, down 11.07% from a year prior.
- Research & Development hit $6.1 million in Q4 2025 for Avanos Medical, up from $6.0 million in the prior quarter.
- Over the last five years, Research & Development for AVNS hit a ceiling of $8.4 million in Q3 2021 and a floor of $5.4 million in Q1 2025.
- Historically, Research & Development has averaged $6.8 million across 5 years, with a median of $6.9 million in 2023.
- Biggest five-year swings in Research & Development: crashed 38.54% in 2021 and later rose 22.03% in 2022.
- Tracing AVNS's Research & Development over 5 years: stood at $5.9 million in 2021, then grew by 22.03% to $7.2 million in 2022, then fell by 5.56% to $6.8 million in 2023, then decreased by 16.18% to $5.7 million in 2024, then increased by 7.02% to $6.1 million in 2025.
- Business Quant data shows Research & Development for AVNS at $6.1 million in Q4 2025, $6.0 million in Q3 2025, and $5.8 million in Q2 2025.